Increased nitric oxide in nasal lavage fluid and nitrotyrosine formation in nasal mucosa - Indices for severe perennial nasal allergy

Clinical and Experimental Allergy

Volumn 28, Issue 5, 1998, Pages 597-605

  Sato, M ^a,b   Fukuyama, N ^a   Sakai, M ^a   Nakazawa, H ^a  

^a TOKAI UNIVERSITY   (Japan)

^b TOKAI UNIVERSITY TOKYO HOSPITAL   (Japan)

Author keywords

Nasal mucosal oedema; Nasal obstruction; Nitric oxide; Nitrotyrosine; Oxidative damage; Perennial nasal allergy; Peroxynitrite; Superoxide

Indexed keywords

3 NITROTYROSINE; CYCLIC GMP; HISTAMINE; NITRIC OXIDE; OXYGEN RADICAL; PEROXYNITRITE; SUPEROXIDE; UNCLASSIFIED DRUG;

ADULT; ALLERGIC REACTION; ARTICLE; BLOOD FLOW; BLOOD VESSEL PERMEABILITY; CONTROLLED STUDY; DISEASE SEVERITY; EDEMA; HEMOGLOBIN DETERMINATION; HUMAN; HUMAN CELL; ISCHEMIA; MAJOR CLINICAL STUDY; NOSE ALLERGY; NOSE MUCUS; OLFACTORY EPITHELIUM; OXIDATION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; TISSUE INJURY;

ADULT; CYCLIC GMP; HEMOGLOBINS; HUMANS; NASAL LAVAGE FLUID; NASAL MUCOSA; NITRATES; NITRIC OXIDE; NITRITES; RHINITIS, ALLERGIC, PERENNIAL; TYROSINE;

EID: 0031809693     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2222.1998.00270.x     Document Type: Article

References (40)

1. Durham SR, Ying S, Varney Va et al. Cytokine messenger RNA expression for IL-3, IL-4, IL-5, and granulocyte/macropharge-colony-stimulating factor in the nasal mucosa after local allergen provocation: relationship to tissue eosionophilia. J Immunol 1992; 148:2390-4.
2. Kroegel C, Yukawa T, Dent G et al. Stimulation of degranulation from human eosinophils by platelet-activating factor. J Immunol 1989; 142:3518-26.
3. Pincus SH, DiNapoli AM. Schooley WR. Superoxide production by eosinophils. Activation by histamine. J Invest Dermatol 1982; 79:53-57.
4. Weiss SJ. Tissue destruction by neutrophils. N Engl J Med 1989; 320:365-76.
5. Kubo N. Effect of antiallergic drugs to receptor binding properties and nasal mucosa vessel. Pharma Medica 1993; 11:169-74.
6. Palmer RMJ, Feerrige AG, Moncadaa S. Nitric oxide release account for the biological activity of endothelium-derived relaxing factor. Nature 1987; 327:524-6.
7. Förstermann U, Closs EI, Pollock JS et al. Nitric oxide synthase isozyme. Characterization, purification, molecular cloning, and functions. Hypertension 1994; 23:1121-31.
8. Moncada S, Palmer RM, Higgs A. Nitric oxide: Physiology, pathology, and pharmacology. Pharmacol Rev 1991; 43:109-42.
9. Nathan C, Xie Q. Nitric oxide synthases: roles, tolls, and controls. Cell 1994; 78:915-18.
10. Radi R, Beckman JS, Bush KM et al. Peroxynitrite oxidation of sulfhydryls. J Biol Chem 1991; 266:4244-50.
11. Ischiropoulos H, Zhu L, Beckmann JS. Peroxynitrite formation from macrophage-derived nitric oxide. Arch Biochem Biophys 1992; 298:446-51.
12. Ito Y. Study of IgG antibody in Japanese cedar pollinosis patients, II. The effect of immunotherapy and seasonal exposure to cedar pollen on specific IgG and IgE antibodies in serum and nasal secretions. Jpn Allergol 1983; 32:985-95.
13. 15N] nitrate in biological fluids. Anal Biochem 1982; 126:131-8.
14. 1) in liver in situ of anesthetized rat measured by reflectance spectrophotometry. Biochem Biopys Acta 1981; 634:1-10.
15. Honma M, Satoh T, Takezawa J et al. An ultrasensitive method for the simultaneous determination of cyclic AMP and cyclic GMP in small-volume samples from blood and tissue. Biochem Med 1977; 18:257-73.
16. Kaur H, Halliwell B. Evidence for nitric oxide-mediated oxidative damage in chronic inflammation. Nitrotyrosine in serum and synovial fluid from rheumatoid patients. FEBS Let 1994; 350:9-12.
17. Crow JP, Beckmann JS. Quantitation of protein tyrosine, 3-nitrotyrosine, and 3-aminotyrosine utilizing HPLC and intrinsic ultraviolet absorbance. Methods 1995; 7:116-20.
18. Fukuyama N, Takebayashi Y, Hida M et al. Clinical evidence of peroxynitrite formation in patients with septic shock -increased plasma nitrotyrosine concentration. Free Rad Biol Med 1997; 22:771-4.
19. Kharitonov SA, Yates D, Robbins RA et al. Increased nitric oxide in exhaled air of asthmatic patients. Lancet 1994; 343: 133-5.
20. Scedin U, Frostell C, Parrsson MG et al. Contribution from upper and lower airways to exhaled endogenous nitric oxide in humans. Acta Anesthesiol Scand 1995; 39:327-32.
21. Lundberg JON, Farkas-Szallasi T, Weitzberg E et al. High nitric oxide production in human paranasal sinuses. Nature Medicine 1995; 1:370-3.
22. Garrelds IM, van Amsterdam JGC, de Graaf-in't Veld C et al. Nitric oxide metabolites in nasal lavage fluid of patients with house dust mite allergy. Thorax 1995; 50:275-9.
23. Normann V, Keith CH. Nitrogen oxides in tobacco smoke. Nature 1965; 205:915-6.
24. Ochoa JB, Udekwu AO, Billiar TR et al. Nitrogen oxide levels in patients after trauma and sepsis. Ann Surg 1991; 214:621-6.
25. Hanazawa T, Motosugi H, Konno A et al. Distribution of NADPH-diaphorase positive nerve fibers in the rat nasal mucosa. Neurosci Lett 1993; 159:71-4.
26. Hanazawa T, Konno A, Kaneko T et al. Nitric oxide synthase-immunoreactive nerve fibers in the nasal mucosa of the rat. Brain Res 1994; 657:7-13.
27. MacMicking JD, Willenberg DO, Weiderman MJ et al. Elevated secretion of reactive nitrogen intermediates by inflammatory leukocytes in hyperacute experimental autoimmune encephalomyelitis: Enhancement by the soluble products of encephalitogenic T cell. J Exp Med 1992; 176:303-7.
28. Punjabi CJ, Laskin DL, Heck DE et al. Production of nitric oxide by murine bone marrow cells. J Immunol 1992; 149: 2179-84.
29. Mautino G, Paul-Eugene N, Chanez P et al. Heterogeneous spontaneous and interleukin-4-induced nitric oxide production by human monocytes. J Lukoc Biol 1994; 54:15-20.
30. Bacci S, Arbi-Riccardi R, Mayer B et al. Localization of nitric oxide synthase immunoreactivity in mast cells of human nasal mucosa. Histochem 1994; 102:89-92.
31. Asakura K, Enomoto K, Azuma E et al. Cyclic nucleotide levels of nasal secretions in allergy patients and control subjects. Arch Otolaryngol 1984; 240:249-53.
32. Austen KF. Reaction mechanisms in the release of mediators of immediate hypersensitivity from human lung tissue. Federation Proc 1974; 33:2256-62.
33. Hasegawa M, Kern EB. The human nasal cycle. Mayo Clin Proc 1977; 52:28-34.
34. Huie RE, Padmaja S. The reaction of NO with superoxide. Free Rad Rec Comm 1993; 18:195-9.
35. Ischiropoulos H, Zhu L, Chen J et al. Peroxynitrite-mediated tyrosine nitration catalyzed by superoxide dismutase. Arch Biochem Biophys 1992; 298:431-7.
36. Karoui H et al. Characterization of sulfer-centered radical intermadiates formed during the oxdation of thiols and sulfite by peroxynitrite. J Biol Chem 1995; 271:6000-9.
37. Castro L et al. Aconitase is readily inactivated by peroxynitrite, but not by its precursor, nitric oxide. J Biol Chem 1994; 269: 29409-15.
38. Yermilov V, Rubio J, Ohshima H. Formation of 8-nitroguanine in DNA treated with peroxynitrite in vivo and its rapid removal from DNA by depurination. FEBS Lett 1995; 376:207-10.
39. Beckmann JS, Ye YZ, Anderson P et al. Extensive nitration of protein tyrosines in human atherosclerosis detected by immunohistochemistry. Biol Chem Hoppe-Seyler 1994; 375:81-8.
40. Kooy NW, Royall JA, Ye YZ et al. Evidence for in vivo peroxynitrite production in human acute lung injury. Am J Respr Crit Care Med 1995; 151:1250-4.